Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
5–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Previous participation in either DMD114117 or DMD114044
Continued use of glucocorticoids
Willing and able to comply with all protocol requirements
Able to give informed consent
French subjects: Eligible for inclusion only if either affiliated to or a beneficiary of a social security category.
You may not be if
Subject experienced a serious adverse event or who met safety stopping criteria that remains unresolved from DMD114117 or DMD114044, which in opinion of the investigator could have been attributable to study medication and is ongoing,
Use of anticoagulants, antithrombotics or antiplatelet agents, previous treatment with investigational drugs,except GSK2402968, within 1 month of the first administration of study medication,
Current or anticipated participation in any investigational clinical studies,
History of significant medical disorder which may confound the interpretation of either efficacy or safety data e.g. current history of renal or liver disease/impairment, history of inflammatory disease.